Melton 3rd, L.J., Thamer, M., Ray, N.F., Chan, J.K., Chesnut 3rd, C.H., Einhorn, T.A., et al. (1997) Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research, 12, 16-23.
https://doi.org/10.1359/jbmr.1997.12.1.16

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.